WORK Medical Technology Group LTD Announces Strategic Partnership with Shanghai Chartwell Medical Device Co., Ltd.
February 28 2025 - 8:00AM
WORK Medical Technology Group LTD (Nasdaq: WOK) (“WORK Medical” or
the “Company”), a supplier of medical devices, through its
subsidiary, Work (Hangzhou) Medical Treatment Equipment Co., Ltd.
and its subsidiaries in China, today announced a strategic
partnership with Shanghai Chartwell Medical Device Co., Ltd.
(“Chartwell Medical”), a high-end medical products manufacturer
across diverse fields, including nuclear medicine, imaging,
infection control, ophthalmology, and rehabilitation robotics, to
drive industrial synergy and accelerate their growth in the
healthcare sector.
The collaboration is to be carried out through
Chartwell Medical’s subsidiaries, including Fuluo (Shanghai)
Medical Equipment Co., Ltd., Fuying (Shanghai) Medical Equipment
Co., Ltd. (“Fuying”), and Fufeng (Suzhou) Medical Treatment
Technology Co., Ltd. (“Fufeng”). Fuying is a joint venture formed
by Chartwell Medical and Sakura Seiki Co., Ltd. Fufeng is a company
engaged in the sales of medical rehabilitation device co-developed
by Chartwell Medical, Toyota Motor Corporation, and Toyota Tsusho
Corporation. To drive mutual growth and unlock new opportunities,
the partnership is expected to address the following
initiatives:
-
Establishing joint investment funds to align industrial and
financial resources;
-
WORK Medical investing in Chartwell Medical or merging Chartwell
into WORK Medical; and
-
Co-investing in key projects in the future, including healthcare
infrastructure, research and development of advanced technology,
and global acquisitions.
Mr. Wu Shuang, chief executive officer and
chairman of the board of directors of WORK Medical, commented, “We
are delighted to enter into a strategic partnership with Chartwell
Medical. This collaboration reflects our shared commitment to
mutual growth and innovation. By leveraging our combined strengths
and resources, we aim to enhance operational efficiency, market
leadership, and international competitiveness. In addition, our
mutual goal is to advance high-end medical technologies, strengthen
competitiveness in the global healthcare industry, and accelerate
the adoption of cutting-edge solutions in domestic markets.”
He added, “As specific cooperation projects with
Chartwell Medical are gradually implemented, we expect our product
portfolio to be further enriched and improved, with an increase in
the proportion of high-value-added products. We expect Work
Medical’s revenue and profits to experience substantial growth over
the next three years. Together, we look forward to fostering a
robust ecosystem with industry partners across China’s healthcare
value chain.”
About WORK Medical Technology Group
LTD
WORK Medical Technology Group LTD is a supplier
of medical devices that develops and manufactures Class I and II
medical devices and sells Class I and II disposable medical devices
through operating subsidiaries in China. The Company has a diverse
product portfolio comprising 21 products, including customized and
multifunctional masks and other medical consumables. All the
products have been sold in 34 provincial-level administrative
regions in China, with 15 of them sold in more than 30 countries
worldwide. The Company has received a number of quality-related
manufacturing designations and has registered 17 products with the
U.S. Food and Drug Administration allowing their products to enter
the U.S. market. For more information, please visit the Company’s
website: https://www.workmedtech.com/corporate.
About Shanghai Chartwell Medical Device
Co., Ltd.
Shanghai Chartwell Medical Device Co., Ltd. is a
supplier, developer, manufacturer, and service provider of high-end
medical devices and consumables, serving China and the broader
Asia-Pacific region. It specializes in integrating and advancing
high-end medical products and technologies, offering a diverse
portfolio that includes hundreds of products across multiple
categories, such as nuclear medicine, radiology, imaging,
endoscopy, infection control, ophthalmology, and regenerative bone
technologies. Chartwell Medical also holds exclusive agency rights
and technical resources for several leading high-end medical brands
from Japan, further strengthening its position in the market. For
more information, please visit Chartwell Medical’s
website: http://www.chartwell.com.cn. All information about
Chartwell Medical Busana has been reviewed and approved by
Chartwell Medical.
Forward-Looking Statements
This press release contains forward-looking
statements, including statements made pursuant to the safe harbor
provisions of the Private Securities Litigation Reform Act of 1995.
These statements may be identified by words such as “aims,”
“anticipates,” “believes,” “could,” “estimates,” “expects,”
“forecasts,” “goal,” “intends,” “may,” “plans,” “possible,”
“potential,” “seeks,” “will,” and variations of these words or
similar expressions that are intended to identify forward-looking
statements. Any such statements in this press release that are not
statements of historical fact may be deemed to be forward-looking
statements.
Any forward-looking statements in this press
release are based on the Company’s current expectations, estimates
and projections only as of the date of this release and are subject
to a number of risks and uncertainties that could cause actual
results to differ materially and adversely from those set forth in
or implied by such forward-looking statements. Although the Company
believes that the expectations expressed in these forward-looking
statements are reasonable, it cannot assure you that such
expectations will turn out to be correct, and the Company cautions
investors that actual results may differ materially from the
anticipated results and encourages investors to review other
factors that may affect its future results set forth in the
Company’s annual report on Form 20-F and other documents filed by
the Company with the SEC. The Company explicitly disclaims any
obligation to update any forward-looking statements except to the
extent required by law.
For more information, please
contact:
WORK Medical Technology Group
LTDInvestor Relations
DepartmentEmail: ir@workmedtech.com
Ascent Investor Relations LLCTina
XiaoPhone: +1-646-932-7242Email: investors@ascent-ir.com
WORK Medical Technology (NASDAQ:WOK)
Historical Stock Chart
From Feb 2025 to Mar 2025
WORK Medical Technology (NASDAQ:WOK)
Historical Stock Chart
From Mar 2024 to Mar 2025